Skip to main content
TipRanks
Go Ultimate75% OFF

Matinas BioPharma (6LJ) Ownership - Who Owns Matinas BioPharma?

0 Followers

Matinas BioPharma (6LJ) Ownership Overview

  • 8.38% Insiders
  • 0.57% Mutual Funds
  • 0.27% ETFs
  • 90.77% Public Companies and Individual Investors

The ownership structure of Matinas BioPharma (DE:6LJ) stock is a mix of institutional, retail, and individual investors. Approximately 0.85% of the company’s stock is owned by Institutional Investors, 8.38% is owned by Insiders, and 90.77% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 12, 2026Adam Stern$400,210

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

DE:6LJ top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.2,851Institution0.29%165
Vanguard2,674Institution0.27%155

FAQ

Who Owns Matinas BioPharma (DE:6LJ)?
According to the latest TipRanks data, approximately 0.85% of the company's stock is held by institutional investors, 8.38% is held by insiders, and 90.77% is held by public companies and individual investors.
What percentage of Matinas BioPharma (DE:6LJ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.85% of Matinas BioPharma (DE:6LJ) stock is held by institutional investors: 0.57% by mutual funds and 0.27% by ETFs.
What percentage of Matinas BioPharma (DE:6LJ) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.77% of Matinas BioPharma (DE:6LJ) stock is held by public companies and individual investors.
Who owns the most shares of Matinas BioPharma (DE:6LJ)?
BlackRock, Inc. owns the most shares of Matinas BioPharma (DE:6LJ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.